1.1(top 50%)
impact factor
29.9K(top 1%)
papers
602.2K(top 1%)
citations
216(top 1%)
h-index
1.1(top 50%)
impact factor
33.3K
all documents
621.9K
doc citations
311(top 2%)
g-index

Top Articles

#TitleJournalYearCitations
12019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular riskAtherosclerosis20191,753
2Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?Atherosclerosis20001,611
32016 ESC/EAS Guidelines for the Management of DyslipidaemiasAtherosclerosis20161,189
4Divergent associations of tissue inhibitors of metalloproteinases-1 and -2 with the prothrombotic/fibrinolytic stateAtherosclerosis20071,107
5Adhesion molecules and atherosclerosisAtherosclerosis2003924
6Conjugated linoleic acid and atherosclerosis in rabbitsAtherosclerosis1994918
7Quantitative assessment of atherosclerotic lesions in miceAtherosclerosis1987894
8Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokinesAtherosclerosis1999862
9Oxysterols and atherosclerosisAtherosclerosis1999824
10Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention1European Society of Cardiology, European Atherosclerosis Society, European Society of Hypertension, International Society of Behavioural Medicine, European Society of General Practice/Family Medicine, European Heart Network.1,2Published simultaneously in the European Heart Journal 1998;19:1434–1503 and the Journal of Hypertension (Summary only) 1998Atherosclerosis1998760
11Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonaseAtherosclerosis1993737
12High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional studyAtherosclerosis2004695
13Lipoprotein Lp(a) and the risk for myocardial infarctionAtherosclerosis1981687
14The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosisDependence on serum LDL levelsAtherosclerosis1986640
15High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transportAtherosclerosis1996638
16Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: A systematic reviewAtherosclerosis2006629
17Carotid plaque, compared with carotid intima-media thickness, more accurately predicts coronary artery disease events: A meta-analysisAtherosclerosis2012601
18The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulationAtherosclerosis2015587
19Influences of age and gender on results of noninvasive brachial–ankle pulse wave velocity measurement—a survey of 12 517 subjectsAtherosclerosis2003572
20Variation in susceptibility to atherosclerosis among inbred strains of miceAtherosclerosis1985561
21ESC/EAS Guidelines for the management of dyslipidaemiasAtherosclerosis2011561
22Serial inbreeding of rabbits with hereditary hyperlipidemia (WHHL-rabbit) *1Incidence and development of atherosclerosis and xanthomaAtherosclerosis1980553
23New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up studyAtherosclerosis1997541
24Vascular oxidative stress, nitric oxide and atherosclerosisAtherosclerosis2014519
25Endothelin is a potent mitogen for rat vascular smooth muscle cellsAtherosclerosis1989515
26Atherosclerotic plaque caps are locally weakened when macrophages density is increasedAtherosclerosis1991513
27HDL and arteriosclerosis: beyond reverse cholesterol transportAtherosclerosis2002511
28Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease riskAtherosclerosis1994506
29Non-alcoholic fatty liver disease and increased risk of cardiovascular diseaseAtherosclerosis2007500
30Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based studyAtherosclerosis1994494
31LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in cultureAtherosclerosis1979493
32A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemiaAtherosclerosis2003490
33Distribution of macrophage polarization markers in human atherosclerosisAtherosclerosis2012490
34Influence of age and menopause on serum lipids and lipoproteins in healthy womenAtherosclerosis1993482
35Postprandial lipoproteins and progression of coronary atherosclerosisAtherosclerosis1994472
36Omega-3 fatty acids and coronary heart disease risk: Clinical and mechanistic perspectivesAtherosclerosis2008470
37The ratio of ankle and arm arterial pressure as an independent predictor of mortalityAtherosclerosis1991465
38Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle sizeAtherosclerosis1992461
39Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitusAtherosclerosis1991458
40Systemic endothelial dysfunction is related to the extent and severity of coronary artery diseaseAtherosclerosis1997451
41Chemokines and atherosclerosisAtherosclerosis1999451
42Progression of carotid atherosclerosis and its determinants: a population-based ultrasonography studyAtherosclerosis1990437
43Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients A new model for the quantitation and follow-up of preclinical atherosclerosis in living human subjectsAtherosclerosis1988425
44Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemiaAtherosclerosis2004425
45Associations of ankle-brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) StudyAtherosclerosis1997424
46Leptin and atherosclerosisAtherosclerosis2006421
47Uric acid and serum antioxidant capacity: a reaction to atherosclerosis?Atherosclerosis2000420
48Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular diseaseAtherosclerosis2014419
492016 European Guidelines on cardiovascular disease prevention in clinical practiceAtherosclerosis2016415
50The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality StudyAtherosclerosis2004414